Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LRRC71 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PEAR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGEF11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INSRR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NTRK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SH2D2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRCC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDGF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRNAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ETV3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ISG20L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FCRL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on